The IPO for Mead Johnson Nutrition Company (NYSE: MJN), a spin-off from Bristol-Myers Squibb (NYSE: BMY), appears on track to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE